Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain, Postoperative | 11 | 2019 | 66 | 3.290 |
Why?
|
| Analgesics | 6 | 2018 | 25 | 2.230 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 222 | 2.000 |
Why?
|
| Analgesia | 6 | 2021 | 15 | 1.770 |
Why?
|
| Anesthetics, Local | 6 | 2016 | 34 | 1.680 |
Why?
|
| Bupivacaine | 4 | 2016 | 18 | 1.480 |
Why?
|
| Dexamethasone | 3 | 2016 | 13 | 1.460 |
Why?
|
| Complex Regional Pain Syndromes | 4 | 2020 | 8 | 1.330 |
Why?
|
| Analgesics, Opioid | 7 | 2021 | 42 | 1.320 |
Why?
|
| Ketamine | 3 | 2019 | 9 | 1.260 |
Why?
|
| Pain Management | 5 | 2021 | 40 | 1.230 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2018 | 93 | 1.220 |
Why?
|
| Motor Activity | 4 | 2017 | 83 | 1.100 |
Why?
|
| Nerve Block | 4 | 2017 | 24 | 1.040 |
Why?
|
| Ketorolac | 2 | 2016 | 5 | 0.980 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 10 | 0.970 |
Why?
|
| Arthroplasty, Replacement, Hip | 4 | 2014 | 135 | 0.930 |
Why?
|
| Animals | 13 | 2020 | 1349 | 0.920 |
Why?
|
| Chronic Pain | 3 | 2021 | 34 | 0.840 |
Why?
|
| Female | 16 | 2021 | 3346 | 0.730 |
Why?
|
| Male | 19 | 2021 | 3399 | 0.720 |
Why?
|
| Acute Pain | 2 | 2018 | 9 | 0.690 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2011 | 7 | 0.680 |
Why?
|
| Pain Measurement | 11 | 2017 | 112 | 0.680 |
Why?
|
| Surgical Wound Infection | 2 | 2018 | 21 | 0.670 |
Why?
|
| Mice | 5 | 2020 | 465 | 0.640 |
Why?
|
| Metformin | 1 | 2020 | 4 | 0.620 |
Why?
|
| Edema | 1 | 2020 | 6 | 0.620 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 6 | 0.620 |
Why?
|
| Neuralgia | 2 | 2019 | 6 | 0.610 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2019 | 5 | 0.610 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2018 | 189 | 0.590 |
Why?
|
| Sciatic Nerve | 2 | 2016 | 7 | 0.570 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 2 | 0.570 |
Why?
|
| Vancomycin | 1 | 2018 | 4 | 0.570 |
Why?
|
| Morphine | 3 | 2021 | 15 | 0.570 |
Why?
|
| Humans | 20 | 2021 | 5837 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 122 | 0.550 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2016 | 4 | 0.550 |
Why?
|
| Pain Threshold | 3 | 2021 | 11 | 0.550 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 11 | 0.520 |
Why?
|
| Clonidine | 2 | 2016 | 6 | 0.510 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 109 | 0.510 |
Why?
|
| Laparotomy | 1 | 2016 | 3 | 0.500 |
Why?
|
| Glucocorticoids | 1 | 2016 | 7 | 0.500 |
Why?
|
| Buprenorphine | 1 | 2016 | 1 | 0.490 |
Why?
|
| Treatment Outcome | 6 | 2019 | 601 | 0.480 |
Why?
|
| Joints | 1 | 2016 | 28 | 0.470 |
Why?
|
| Arthralgia | 1 | 2016 | 39 | 0.460 |
Why?
|
| Time Factors | 6 | 2016 | 374 | 0.430 |
Why?
|
| Random Allocation | 3 | 2020 | 33 | 0.430 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 4 | 2009 | 11 | 0.410 |
Why?
|
| Middle Aged | 10 | 2018 | 1775 | 0.400 |
Why?
|
| Low Back Pain | 3 | 2021 | 35 | 0.380 |
Why?
|
| Zygapophyseal Joint | 1 | 2012 | 11 | 0.370 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 24 | 0.360 |
Why?
|
| Substance P | 1 | 2011 | 4 | 0.360 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2011 | 4 | 0.360 |
Why?
|
| Glutamic Acid | 1 | 2011 | 6 | 0.360 |
Why?
|
| Norepinephrine | 1 | 2011 | 8 | 0.360 |
Why?
|
| Hip Joint | 2 | 2010 | 88 | 0.350 |
Why?
|
| Anesthesia, Conduction | 4 | 2021 | 8 | 0.340 |
Why?
|
| Analgesia, Epidural | 2 | 2017 | 21 | 0.320 |
Why?
|
| Dinoprostone | 2 | 2007 | 6 | 0.300 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 36 | 0.300 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2015 | 9 | 0.290 |
Why?
|
| Prospective Studies | 5 | 2011 | 411 | 0.280 |
Why?
|
| Hypoglycemic Agents | 2 | 2020 | 16 | 0.270 |
Why?
|
| Injections | 3 | 2016 | 12 | 0.270 |
Why?
|
| Lactones | 1 | 2007 | 3 | 0.260 |
Why?
|
| Preoperative Care | 1 | 2007 | 12 | 0.260 |
Why?
|
| Sulfones | 1 | 2007 | 7 | 0.260 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 15 | 0.260 |
Why?
|
| Aged | 6 | 2017 | 1860 | 0.260 |
Why?
|
| Behavior, Animal | 3 | 2016 | 24 | 0.260 |
Why?
|
| Drug Combinations | 2 | 2016 | 9 | 0.250 |
Why?
|
| Interleukins | 1 | 2006 | 8 | 0.240 |
Why?
|
| Central Nervous System | 1 | 2006 | 19 | 0.240 |
Why?
|
| Postoperative Complications | 1 | 2007 | 154 | 0.240 |
Why?
|
| Injections, Spinal | 4 | 2018 | 12 | 0.220 |
Why?
|
| Rats | 5 | 2018 | 282 | 0.210 |
Why?
|
| Pregabalin | 3 | 2011 | 5 | 0.190 |
Why?
|
| Fentanyl | 1 | 2002 | 8 | 0.190 |
Why?
|
| Magnesium | 1 | 2002 | 24 | 0.190 |
Why?
|
| Analgesia, Obstetrical | 1 | 2002 | 16 | 0.190 |
Why?
|
| Cytokines | 2 | 2015 | 63 | 0.170 |
Why?
|
| Physicians | 1 | 2021 | 27 | 0.160 |
Why?
|
| Double-Blind Method | 3 | 2021 | 78 | 0.160 |
Why?
|
| Chicago | 2 | 2011 | 239 | 0.160 |
Why?
|
| Tibial Fractures | 1 | 2020 | 3 | 0.160 |
Why?
|
| Rodentia | 1 | 2018 | 3 | 0.140 |
Why?
|
| Anesthesiologists | 1 | 2018 | 2 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2018 | 21 | 0.140 |
Why?
|
| Hostility | 1 | 2018 | 4 | 0.140 |
Why?
|
| Spouses | 1 | 2018 | 6 | 0.140 |
Why?
|
| Administration, Oral | 1 | 2018 | 21 | 0.140 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 26 | 0.140 |
Why?
|
| Spinal Cord | 2 | 2012 | 23 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2018 | 94 | 0.140 |
Why?
|
| Quality of Life | 1 | 2018 | 108 | 0.130 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 28 | 0.130 |
Why?
|
| Hyperalgesia | 1 | 2017 | 27 | 0.130 |
Why?
|
| Wound Closure Techniques | 1 | 2016 | 4 | 0.130 |
Why?
|
| Risk Factors | 1 | 2018 | 499 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2007 | 54 | 0.120 |
Why?
|
| Models, Animal | 1 | 2016 | 62 | 0.120 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 3 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 35 | 0.120 |
Why?
|
| Herpes Zoster | 1 | 2015 | 1 | 0.120 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2015 | 1 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2015 | 11 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3 | 0.110 |
Why?
|
| Insulin | 1 | 2015 | 16 | 0.110 |
Why?
|
| Recovery of Function | 2 | 2017 | 64 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2015 | 30 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 30 | 0.110 |
Why?
|
| Pain Clinics | 1 | 2014 | 1 | 0.100 |
Why?
|
| Lidocaine | 2 | 2012 | 13 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2014 | 5 | 0.100 |
Why?
|
| Adult | 5 | 2018 | 1670 | 0.100 |
Why?
|
| Pain | 2 | 2021 | 82 | 0.090 |
Why?
|
| Perioperative Period | 1 | 2011 | 2 | 0.090 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2011 | 5 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2009 | 71 | 0.090 |
Why?
|
| Spinal Puncture | 1 | 2011 | 7 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2015 | 29 | 0.090 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2011 | 16 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2011 | 77 | 0.080 |
Why?
|
| Psychometrics | 1 | 2010 | 52 | 0.080 |
Why?
|
| Diabetic Neuropathies | 1 | 2010 | 3 | 0.080 |
Why?
|
| Amides | 1 | 2010 | 5 | 0.080 |
Why?
|
| Length of Stay | 1 | 2010 | 45 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2009 | 8 | 0.080 |
Why?
|
| Anesthesia, Epidural | 1 | 2009 | 6 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 187 | 0.080 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2009 | 4 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 6 | 0.080 |
Why?
|
| Reoperation | 1 | 2010 | 146 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 51 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 19 | 0.070 |
Why?
|
| Range of Motion, Articular | 1 | 2009 | 136 | 0.070 |
Why?
|
| Sleep | 1 | 2009 | 88 | 0.070 |
Why?
|
| United States | 2 | 2021 | 502 | 0.070 |
Why?
|
| Terrorism | 1 | 2007 | 2 | 0.070 |
Why?
|
| Pain, Intractable | 1 | 2007 | 5 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 129 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2007 | 46 | 0.060 |
Why?
|
| Incidence | 1 | 2007 | 165 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 333 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2006 | 13 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2006 | 8 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2005 | 41 | 0.050 |
Why?
|
| Fetal Monitoring | 1 | 2002 | 3 | 0.050 |
Why?
|
| Heart Rate, Fetal | 1 | 2002 | 3 | 0.050 |
Why?
|
| Pruritus | 1 | 2002 | 4 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 8 | 0.050 |
Why?
|
| Indans | 1 | 2002 | 4 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 14 | 0.050 |
Why?
|
| Heart Rate | 1 | 2002 | 25 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2002 | 48 | 0.050 |
Why?
|
| Pregnancy | 1 | 2002 | 103 | 0.050 |
Why?
|
| Epinephrine | 2 | 2012 | 14 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 14 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 21 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2018 | 13 | 0.030 |
Why?
|
| Medical Records | 1 | 2018 | 5 | 0.030 |
Why?
|
| Thigh | 1 | 2017 | 6 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2017 | 45 | 0.030 |
Why?
|
| Walking | 1 | 2017 | 53 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 59 | 0.030 |
Why?
|
| Herpesvirus 3, Human | 1 | 2015 | 1 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 2 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 2015 | 8 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 12 | 0.030 |
Why?
|
| Streptozocin | 1 | 2015 | 1 | 0.030 |
Why?
|
| Biomarkers | 1 | 2015 | 141 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 406 | 0.030 |
Why?
|
| Young Adult | 1 | 2015 | 421 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 112 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 62 | 0.020 |
Why?
|
| Sensation | 1 | 2010 | 4 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2010 | 4 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 16 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 163 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 203 | 0.020 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2007 | 2 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 7 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 35 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 54 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 309 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2005 | 60 | 0.010 |
Why?
|
| Depression | 1 | 2005 | 113 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 5 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 12 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 110 | 0.010 |
Why?
|